ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 69 filers reported holding ARCELLX INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $141,605,084 | +13.5% | 3,946,630 | 0.0% | 72.57% | +34.9% |
| Q2 2023 | $124,792,441 | -26.4% | 3,946,630 | -28.2% | 53.81% | -14.7% |
| Q1 2023 | $169,455,216 | -0.5% | 5,500,007 | 0.0% | 63.12% | +1.5% |
| Q4 2022 | $170,390,217 | +65.1% | 5,500,007 | 0.0% | 62.20% | +31.8% |
| Q3 2022 | $103,235,000 | +3.8% | 5,500,007 | 0.0% | 47.19% | -3.0% |
| Q2 2022 | $99,440,000 | +29.0% | 5,500,007 | 0.0% | 48.67% | +23.3% |
| Q1 2022 | $77,110,000 | – | 5,500,007 | – | 39.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 3,946,630 | $141,605,084 | 72.57% |
| NEA Management Company, LLC | 3,745,262 | $134,380,001 | 10.38% |
| Paradigm Biocapital Advisors LP | 2,953,122 | $105,958,017 | 7.19% |
| Samsara BioCapital, LLC | 613,921 | $22,027,485 | 6.74% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,869,967 | $102,974,416 | 5.56% |
| Perceptive Advisors | 3,965,978 | $142,299,291 | 4.75% |
| Cormorant Asset Management, LP | 2,150,000 | $77,142,000 | 4.50% |
| Affinity Asset Advisors, LLC | 400,000 | $14,352,000 | 4.04% |
| Novo Holdings A/S | 1,075,000 | $38,571,000 | 2.85% |
| Soleus Capital Management, L.P. | 643,777 | $23,098,719 | 2.13% |